Agree that things need to change. A lot of money has been spent only for the strategy now to build a stronger core business before being more adventurous. I’d really love to know what the plan is re US - don’t we have. Clinical trial running still?
Ann: Quarterly Report Webcast Details 3Q24, page-12
Add MVP (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
49.0¢ |
Change
0.020(4.26%) |
Mkt cap ! $42.28M | |||
| Open | High | Low | Value | Volume |
| 47.0¢ | 51.0¢ | 47.0¢ | $58.40K | 121.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 49243 | 47.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 51.0¢ | 999 | 1 |
View Market Depth
| Last trade - 15.58pm 19/07/2024 (20 minute delay) ? |
| MVP (ASX) Chart |